Study of inelastic nuclear interactions of 400 GeV/c protons in bent silicon crystals for beam steering purposes.

Inelastic nuclear interaction probability of 400 GeV/c protons interacting with bent silicon crystals was investigated, in particular for both types of crystals installed at the CERN Large Hadron Collider for beam collimation purposes. In comparison to amorphous scattering interaction, in planar channeling this probability is ∼ 36 % for the quasi-mosaic type (planes (111)), and ∼ 27 % for the strip type (planes (110)). Moreover, the absolute inelastic nuclear interaction probability in the axial channeling orientation, along the ⟨ 110 ⟩ axis, was estimated for the first time, finding a value of 0.6 % for a crystal 2 mm long along the beam direction, with a bending angle of 55 µ rad. This value is more than two times lower with respect to the planar channeling orientation of the same crystal, and increases with the vertical angular misalignment. Finally, the correlation between the inelastic nuclear interaction probability in the planar channeling and the silicon crystal curvature is reported.

Dependence of the electron-cloud instability on the beam energy.

The electron cloud (EC) can be formed in the beam pipe of a circular accelerator if the secondary emission yield (SEY) of the inner surface is larger than 1, and it can detrimentally affect the circulating beam. Understanding the underlying physics and defining the scaling laws of this effect is indispensable to steer the upgrade plans of the existing machines and the design of new ones. The single bunch EC instability (ECI) is shown to be strongly affected by the transverse beam size. Transversely, smaller beams going through an electron cloud generate higher electron peak densities and lower the intensity threshold to make the beam unstable. In particular, since higher energy beams have smaller transverse sizes (for equal normalized transverse emittances), the scaling of the ECI threshold with the beam energy turns out to be surprisingly unfavorable.

Physical specifications of clinical proton beams from a synchrotron.

Tumor treatment with charged particle beams is a quickly developing field aimed to translate the potential advantages offered by the superior physical dose distribution and relative biological effectiveness of heavy charged particles into a real improvement of tumor therapy. To this purpose the new proton and light-ion radiation therapy facilities must be designed according to strict clinical specifications to provide a reliable and effective tool against cancer. This paper provides the performance specifications of the accelerator and of the beam transport and delivery systems of the Italian Hadrontherapy Centre, which should be satisfied to meet the clinical specifications. A discussion is given on the requirements on energy range, energy variability, beam intensity, lateral penumbra, distal dose falloff, source-to-surface distance, time structure of the extracted beam, raster scanning system specifications, and beam abort time. Though the physical specifications are given for a particular accelerator, they can be used as a general guideline for the design of future biomedical particle accelerator facilities.

[The hadron therapy project]. / Ii progetto adroterapia.

The neologism "hadrontherapy" means radiotherapy with hadrons, which are the particles constituted by quarks, such as protons, neutrons and ions. The theoretical considerations about the clinical advantages this treatment modality can yield and the results obtained at the centers where it has already been used justify the proposal to project a center of this kind also in our Country. To this purpose, two of the authors of this paper (U. Amaldi, G. Tosi) founded the TERA Group formed by physicists, engineers and radiotherapists who work in close collaboration on a feasibility study for a hadrontherapy facility. The first aim of the Hadrontherapy Project is to design a center equipped with a synchrotron which, at the beginning, will accelerate negative hydrogen ions (H-) which will first produce 70-250 MeV proton beams and, then accelerate light ions (up to 16O) to 430 MeV/amu. This accelerator will serve four or five treatment rooms where patients can be irradiated simultaneously. Two rooms will be equipped with a fixed horizontal beam for the treatment of eye, head and neck tumors; the others will be equipped with rotating gantries to administer, in any clinical situation, really adequate treatment. Such a unit, when enough experience is fained, will allow at least 1000 patients to be treated yearly. The synchrotron injector will be designed so as to allow, parallel to the radiotherapy activities, other applications of medical and biological interest such as: the production of radioisotopes for diagnostic use (especially positron emitters), the analysis of trace elements through the PIXE technique and the production of thermal and epithermal neutrons for boron neutron capture therapy.

Immunofluorescence study of fibronectin distribution in the developing chick embryo striated muscles.

This paper reports immunofluorescence data concerning fibronectin distribution in chick embryo striated muscle buds, i.e. myotomes and heart bud, in stages following their differentiation. At earliest developmental stages (12-15 HH) no fibronectin could be observed between the still poorly differentiated myoblasts of myotomes and of the splanchnopleure. Fibronectin, however, was observed among differentiated myoblasts of the myocardial ventral portion. In myotomes at later stages (16-18 HH), a few thin strands of fibronectin were observed between the myotomal and dermatomal laminae; this pattern became more marked between stages 17 and 26 HH. It is concluded that during myogenesis, fibronectin is absent at the earliest differentiation stages. A faint fibronectin-containing matrix is detectable at later stages and becomes more evident only in mature muscle tissue. This pattern is consistent with a role of fibronectin in the process of tissue organization.